Cohort Profile:The Shandong Adenomyosis Cohort of Population Undergoing Reproductive Technology (SAart)

Active, not recruitingOBSERVATIONAL
Enrollment

2,241

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

January 1, 2027

Study Completion Date

January 1, 2030

Conditions
Adenomyosisin Vitro Fertilization
Interventions
OTHER

Treatment protocol

Treatment options for ovarian stimulation include long-acting and antagonist regimens and other ovulation induction regimens. Options for frozen embryo transfer include natural protocols, mild ovarian stimulation regimens, hormone replacement therapy (HRT) regimens, and down-regulated combined HRT regimens. The treatment regimen is refined in the above protocol. The treatment of patients follows the principles of real-world clinical practice.

Trial Locations (1)

250033

The Second Clinical Hospital of Shandong University, Jinan

All Listed Sponsors
lead

The Second Hospital of Shandong University

OTHER

NCT06604091 - Cohort Profile:The Shandong Adenomyosis Cohort of Population Undergoing Reproductive Technology (SAart) | Biotech Hunter | Biotech Hunter